The Food and Drug Administration (FDA) has approved labeling updates regarding dosage and warnings for Requip (ropinirole; GlaxoSmithKline) tablets. The Food and Drug Administration (FDA) has approved ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
Ropinirole (as HCl) 2mg, 4mg, 6mg, 8mg, 12mg; ext-rel tabs. The precise mechanism of action of ropinirole as a treatment for Parkinson’s disease and RLS is unknown, although it is thought to be ...
Some people with Parkinson’s disease develop severe withdrawal symptoms when they try to taper off a widely used type of Parkinson’s drug, researchers are reporting. The drugs, called dopamine ...
Research Triangle Park, NC (December 15, 2004) – Study results published today in the journal Movement Disorders show that Requipâ(ropinirole HCl) Tablets effectively treats the symptoms of primary ...
Some people with Parkinson’s disease develop severe withdrawal symptoms when they try to taper off a widely used type of Parkinson’s drug, researchers are reporting. The drugs, called dopamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback